Home

kaynakça Birçok tehlikeli durum ritim nf kappa b ppar disease model program pedicab kaynak

Frontiers | Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of  Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases
Frontiers | Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases  by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology
Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR–α Activators | Arteriosclerosis, Thrombosis, and Vascular Biology

NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression  of hepatic steatosis - ScienceDirect
NF-κB/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis - ScienceDirect

IJMS | Free Full-Text | The Role of PPAR Alpha in the Modulation of Innate  Immunity | HTML
IJMS | Free Full-Text | The Role of PPAR Alpha in the Modulation of Innate Immunity | HTML

Frontiers | Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic  and Environmental Risk Factors from Cell to Humans
Frontiers | Nuclear Factor-Kappa B and Alzheimer Disease, Unifying Genetic and Environmental Risk Factors from Cell to Humans

NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene

Roles of PPARγ/NF-κB Signaling Pathway in the Pathogenesis of Intrahepatic  Cholestasis of Pregnancy | PLOS ONE
Roles of PPARγ/NF-κB Signaling Pathway in the Pathogenesis of Intrahepatic Cholestasis of Pregnancy | PLOS ONE

Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to  Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast  Database and a Deep Learning Artificial Neural Network Model-Based Approach  | Chemical Research
Development of Adverse Outcome Pathway for PPARγ Antagonism Leading to Pulmonary Fibrosis and Chemical Selection for Its Validation: ToxCast Database and a Deep Learning Artificial Neural Network Model-Based Approach | Chemical Research

NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene

NF-κB - Wikipedia
NF-κB - Wikipedia

Regulation of NF-κB pathway by PPAR agonists in CNS diseases. The... |  Download Scientific Diagram
Regulation of NF-κB pathway by PPAR agonists in CNS diseases. The... | Download Scientific Diagram

Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental  Targeting for the Treatment of Inflammatory Bowel Diseases
Frontiers | Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases

PPAR Regulation of Inflammatory Signaling in CNS Diseases
PPAR Regulation of Inflammatory Signaling in CNS Diseases

PPARγ and PGC-1α as Therapeutic Targets in Parkinson's | SpringerLink
PPARγ and PGC-1α as Therapeutic Targets in Parkinson's | SpringerLink

Self-regulation of NF-κB activity and COX-2 expression. In inflammatory...  | Download Scientific Diagram
Self-regulation of NF-κB activity and COX-2 expression. In inflammatory... | Download Scientific Diagram

Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of  Alveolar Macrophage Macrophage Colony-Stimulating Factor | The Journal of  Immunology
Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor | The Journal of Immunology

Antioxidant mechanisms of peroxisome-proliferator-activated receptors.... |  Download Scientific Diagram
Antioxidant mechanisms of peroxisome-proliferator-activated receptors.... | Download Scientific Diagram

Therapeutic potential of PPARγ natural agonists in liver diseases - Wu -  2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Therapeutic potential of PPARγ natural agonists in liver diseases - Wu - 2020 - Journal of Cellular and Molecular Medicine - Wiley Online Library

Frontiers | The Protective Effects of Peroxisome Proliferator-Activated  Receptor Gamma in Cerebral Ischemia-Reperfusion Injury
Frontiers | The Protective Effects of Peroxisome Proliferator-Activated Receptor Gamma in Cerebral Ischemia-Reperfusion Injury

NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy
NF-κB signaling in inflammation | Signal Transduction and Targeted Therapy

Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by  Interacting with p65 | The Journal of Immunology
Herpes Simplex Virus Type 2 Glycoprotein D Inhibits NF-κB Activation by Interacting with p65 | The Journal of Immunology

NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews  Immunology
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology

Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis,  Thrombosis, and Vascular Biology
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology

Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for  Antiparkinsonism Therapeutics | ACS Chemical Neuroscience
Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics | ACS Chemical Neuroscience

Regulation of neuroinflammation by PPAR agonists in CNS diseases.... |  Download Scientific Diagram
Regulation of neuroinflammation by PPAR agonists in CNS diseases.... | Download Scientific Diagram